These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

442 related articles for article (PubMed ID: 15771038)

  • 1. [Prevention of clogging of biliary stents by administration of levofloxacin and ursodeoxycholic acid].
    Sciumè C; Geraci G; Pisello F; Facella T; Li Volsi F; Modica G
    Chir Ital; 2004; 56(6):831-7. PubMed ID: 15771038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ofloxacin and ursodeoxycholic acid versus ursodeoxycholic acid alone to prevent occlusion of biliary stents: a prospective, randomized trial.
    Halm U; Schiefke ; Fleig WE; Mössner J; Keim V
    Endoscopy; 2001 Jun; 33(6):491-4. PubMed ID: 11437041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term ciprofloxacin treatment for the prevention of biliary stent blockage: a prospective randomized study.
    Sung JJ; Sollano JD; Lai CW; Ismael A; Yung MY; Tumala I; Chung SC
    Am J Gastroenterol; 1999 Nov; 94(11):3197-201. PubMed ID: 10566714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ursodeoxycholic acid and/or antibiotics for prevention of biliary stent occlusion.
    Galandi D; Schwarzer G; Bassler D; Allgaier HP
    Cochrane Database Syst Rev; 2002; 2002(3):CD003043. PubMed ID: 12137669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective randomized trial of Teflon versus polyethylene stents for distal malignant biliary obstruction.
    van Berkel AM; Boland C; Redekop WK; Bergman JJ; Groen AK; Tytgat GN; Huibregtse K
    Endoscopy; 1998 Oct; 30(8):681-6. PubMed ID: 9865556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is the addition of choleretic agents in multiple double-pigtail biliary stents effective for difficult common bile duct stones in elderly patients? A prospective, multicenter study.
    Lee TH; Han JH; Kim HJ; Park SM; Park SH; Kim SJ
    Gastrointest Endosc; 2011 Jul; 74(1):96-102. PubMed ID: 21531412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of combined biliary and duodenal stenting in patients with malignant biliary and duodenal obstruction.
    Kim KO; Kim TN; Lee HC
    Scand J Gastroenterol; 2012 Sep; 47(8-9):962-7. PubMed ID: 22571283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of biliary stent occlusion by ursodeoxycholic acid plus norfloxacin: a multicenter randomized trial.
    De Lédinghen V; Person B; Legoux JL; Le Sidaner A; Desaint B; Greef M; Moesch C; Grollier G; Ingrand P; Sautereau D; Beauchant M
    Dig Dis Sci; 2000 Jan; 45(1):145-50. PubMed ID: 10695627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Occlusion rate and complications of plastic biliary stent placement in patients undergoing neoadjuvant chemoradiotherapy for pancreatic cancer with malignant biliary obstruction.
    Boulay BR; Gardner TB; Gordon SR
    J Clin Gastroenterol; 2010 Jul; 44(6):452-5. PubMed ID: 20179612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of expandable metallic biliary stents in resectable pancreatic cancer.
    Wasan SM; Ross WA; Staerkel GA; Lee JH
    Am J Gastroenterol; 2005 Sep; 100(9):2056-61. PubMed ID: 16128952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of ursodeoxycholic acid and endoscopic sphincterotomy in long-term stenting for common bile duct stones.
    Nishizawa T; Suzuki H; Takahashi M; Kaneko H; Suzuki M; Hibi T
    J Gastroenterol Hepatol; 2013 Jan; 28(1):63-7. PubMed ID: 23094786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized trial of prevention of biliary stent occlusion by ursodeoxycholic acid plus norfloxacin.
    Tarnasky PR; Cotton PB
    Gastrointest Endosc; 1995 Jul; 42(1):103-4. PubMed ID: 7557168
    [No Abstract]   [Full Text] [Related]  

  • 13. A comparison of metal and plastic stents for the relief of jaundice in unresectable malignant biliary obstruction in Korea: an emphasis on cost-effectiveness in a country with a low ERCP cost.
    Yoon WJ; Ryu JK; Yang KY; Paik WH; Lee JK; Woo SM; Park JK; Kim YT; Yoon YB
    Gastrointest Endosc; 2009 Aug; 70(2):284-9. PubMed ID: 19539921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human application of a metallic stent covered with a paclitaxel-incorporated membrane for malignant biliary obstruction: multicenter pilot study.
    Suk KT; Kim JW; Kim HS; Baik SK; Oh SJ; Lee SJ; Kim HG; Lee DH; Won YH; Lee DK
    Gastrointest Endosc; 2007 Oct; 66(4):798-803. PubMed ID: 17905025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Should endoscopic stenting be the initial treatment of malignant biliary obstruction?
    Earnshaw JJ; Hayter JP; Teasdale C; Beckly DE
    Ann R Coll Surg Engl; 1992 Sep; 74(5):338-41. PubMed ID: 1384416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uncovered Hanaro Versus Luminex metal stents for palliation of malignant biliary strictures.
    Katsinelos P; Kountouras J; Paroutoglou G; Paikos D; Moschos J; Chatzimavroudis G; Zavos C; Makrigiannis E
    J Clin Gastroenterol; 2008; 42(5):539-45. PubMed ID: 18277888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective, randomized multicenter trial comparing DoubleLayer and polyethylene stents for malignant distal common bile duct strictures.
    Tringali A; Mutignani M; Perri V; Zuccalà G; Cipolletta L; Bianco MA; Rotondano G; Philipper M; Schumacher B; Neuhaus H; Schmit A; Devière J; Costamagna G
    Endoscopy; 2003 Dec; 35(12):992-7. PubMed ID: 14648409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of the Niti-D biliary uncovered stent and the uncovered Wallstent in malignant biliary obstruction.
    Yang KY; Ryu JK; Seo JK; Woo SM; Park JK; Kim YT; Yoon YB
    Gastrointest Endosc; 2009 Jul; 70(1):45-51. PubMed ID: 19559832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malignant bile-duct obstruction: experience with self-expanding metal endoprostheses (Wallstents) in Austria.
    Schöfl R; Brownstone E; Reichel W; Fortunat W; Doblhofer F; Samec HJ; Brandstätter G; Stupnicki T; Pamperl H; Schreiber P
    Endoscopy; 1994 Sep; 26(7):592-6. PubMed ID: 7528135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biliary secretion of bile acids and lipids in primary sclerosing cholangitis. Influence of cholestasis and effect of ursodeoxycholic acid treatment.
    Stiehl A; Rudolph G; Sauer P; Theilmann L
    J Hepatol; 1995 Sep; 23(3):283-9. PubMed ID: 8550992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.